The purpose of the Clinical Trials Support Unit (CTSU) is to provide a central Cancer Center resource to coordinate and assist with all cancer-related clinical research within the affiliated hospitals and ambulatory care centers of BCM. It will foster the establishment and maintenance of clinical trial related infrastructure, especially for investigators and institutions with less prior experience and knowledge in this area. By this mechanism, it will enable and increase clinical trial enrollment to a wide spectrum of cancer-related studies. The Unit's efforts will particularly target hospitals and institutions with a higher proportion of minority and economically disadvantaged patients, providing greater access to participation in clinical research for these populations. In addition the CTSU will facilitate liaison with external co-investigators and cooperative groups, federal agencies, and the pharmaceutical industry. The CTSU will provide three major services to Cancer Center investigators: 1) Assistance with regulatory and administrative matters relating to clinical research and trials including IRB compliance and approval, ongoing amendments and renewal, external agency compliance (such as the FDA), maintenance of regulatory files, and assistance with internal and external audits; 2) Provision of research nursing/clinical trials management especially to less experienced investigators or those with limited programs; 3) Provision of data management and bioinformatics expertise including database instruction and maintenance and internal audits. The CTSU will thus provide efficient, cost-effective support to aid Cancer Center investigators in the conduct of scientifically valuable cancer clinical trials and will improve access to these trials, especially for underserved minorities. The main offices of the CTSU are located within the Cancer Center administrative offices on the fourth floor of the Cullen Bldg at Baylor College of Medicine. Satellite offices for Research Nursing/Research Coordinators are located in each of the College's major affiliated clinical facilities including the Baylor Ambulatory Care Clinic, St. Luke's Episcopal Hospital, Texas Children's Hospital, the Ben Taub General Hospital, and the Michael E. DeBakey VA Medical Center. The Resource Leader is Martha Mims, M.D./Ph.D.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA125123-03
Application #
7900433
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
3
Fiscal Year
2009
Total Cost
$119,434
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Yin, Jiani; Chen, Wu; Chao, Eugene S et al. (2018) Otud7a Knockout Mice Recapitulate Many Neurological Features of 15q13.3 Microdeletion Syndrome. Am J Hum Genet 102:296-308
Jones, Kathryn; Versteeg, Leroy; Damania, Ashish et al. (2018) Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease. Infect Immun 86:
Madan, Simran; Kron, Bettina; Jin, Zixue et al. (2018) Arginase overexpression in neurons and its effect on traumatic brain injury. Mol Genet Metab 125:112-117
Kornberg, Michael D; Bhargava, Pavan; Kim, Paul M et al. (2018) Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science 360:449-453
Koo, Sue-Jie; Szczesny, Bartosz; Wan, Xianxiu et al. (2018) Pentose Phosphate Shunt Modulates Reactive Oxygen Species and Nitric Oxide Production Controlling Trypanosoma cruzi in Macrophages. Front Immunol 9:202
Hsu, Joanne I; Dayaram, Tajhal; Tovy, Ayala et al. (2018) PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy. Cell Stem Cell 23:700-713.e6
Singh, Sunita; Jangid, Rahul K; Crowder, Alyssa et al. (2018) Foxi3 transcription factor activity is mediated by a C-terminal transactivation domain and regulated by the Protein Phosphatase 2A (PP2A) complex. Sci Rep 8:17249
Lulla, Premal D; Hill, LaQuisa C; Ramos, Carlos A et al. (2018) The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma. Clin Adv Hematol Oncol 16:375-386
De Maio, Antonia; Yalamanchili, Hari Krishna; Adamski, Carolyn J et al. (2018) RBM17 Interacts with U2SURP and CHERP to Regulate Expression and Splicing of RNA-Processing Proteins. Cell Rep 25:726-736.e7
Bayrer, James R; Wang, Hongtao; Nattiv, Roy et al. (2018) LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival. Nat Commun 9:4055

Showing the most recent 10 out of 991 publications